Chapter 44: Pediatric Cancer Nursing Care

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to The Deep Dive, where we take complex, often overwhelming sources,

and distill them into the high -yield knowledge you need to be informed, ready for the exam, or simply ready for the real world.

Today, we are tackling one of the most clinically and emotionally demanding areas in pediatric medicine,

caring for the child with cancer.

This is a deep dive into the very core of maternal child nursing care, focusing specifically on pediatric oncology.

It's a field defined not just by pathology, but by the sheer intensity of the treatment and the life -altering challenges faced by the family.

And the stakes are so high.

Cancer remains the leading cause of death from disease after infancy in the U .S.

It does.

So understanding the evidence -based care outlined in this chapter is really non -negotiable for safe practice.

I think the source material here is fantastic because it immediately sets the foundation.

It introduces five core concepts that have to guide every single action a nurse takes in this field.

Let's lay those pillars out.

Absolutely.

Think of these as the lens you view everything through.

First, you've got cellular regulation.

That's the actual biology of the cancer itself.

Okay.

Second, and this is maybe the most crucial, is family dynamics.

You are treating the child, but the entire family unit is your patient.

You really can't separate.

You can't.

Third, patient and family education.

Clear, consistent communication drives adherence.

It reduces anxiety, and it really empowers the parents.

Fourth is nutrition.

Maintaining caloric and protein intake is just essential for enduring these really toxic treatments.

And finally, infection, the ever -present most life -threatening complication of therapy.

So that sets our mission for today.

We're distilling the clinical essentials, the key assessment findings, and the absolute life -saving priority interventions directly from this material.

We want to give you a focused guide to competent care.

Right.

So before we dive into the clinical side, we have to ground ourselves in the facts of the disease.

The epidemiology.

Exactly.

The good news is that childhood cancer is thankfully rare.

We're talking roughly 16 ,400 new cases diagnosed annually in the U .S.

for kids under 20.

But the story of survival, that's one of the great medical triumphs of the last 50 years.

Give us the scale of that improvement.

It's just dramatic.

In the 1960s, the overall three -year survival rate was a devastating 28%.

Today,

thanks to cooperative clinical trials, multimodal therapy, and just extraordinary supportive care, that overall three -year survival rate now exceeds 80%.

That is just immense progress.

But the text immediately points out a pretty significant global disparity.

It does.

And it's important to know, while high -income countries boast these incredible stats, the rates in low -income countries lag severely behind.

This just highlights a persistent global inequity and access to specialized care, diagnostics, and all the supportive therapies you need to manage high -dose chemo.

So statistically, who is most likely to be affected?

Are there demographic trends we should be aware of?

There are.

There are two distinct peaks in incidence based on age, and the cancers are different in each.

We see one peak in infants and very young children, from zero to four years old.

And what are we seeing there?

That's where cancers like neuroblastoma and rednoblastoma are more common.

The second peak is in adolescence, ages 15 to 19, and that's where we see higher rates of lymphoma and sarcoma.

And the data also suggests differences based on sex and race.

Correct.

Males have a slightly higher overall incidence, about a 1 .1 to 1 ratio compared to females.

This is largely driven by higher rates of acute lymphoblastic leukemia, or ALLO, non -Hodgkin lymphoma, and CNS tumors.

Okay.

And race.

Regarding race, white children show a higher overall incidence, specifically in cancers like AL, Ewing, sarcoma, and melanoma.

Now we get to maybe the most difficult conversation a nurse will have with a parent.

The why.

Parents inevitably ask, could I have prevented this?

This is such a profound moment for counseling and support.

It's crucial for the nurse to communicate clearly that the lifestyle factors that drive adult cancer risk—tobacco, diet, sun exposure—play little to no role here.

So that's the key message.

That's the key message.

The text explicitly states that external or environmental factors are minor, with exceptions being like high -dose radiation or prior chemo.

The message is one of reassurance.

This was not preventable by ordinary means.

So if it's not external, then the focus has to be intrinsic.

Tell us about the role of genetics.

The evidence just overwhelmingly points to genetic and intrinsic mechanisms.

The risk factors identified include things like advanced parental age, high birth weight, certain congenital anomalies, and most critically, these inherited cancer predisposition syndromes.

Like what?

A classic example is the germline mutation associated with retinoblastoma, where the RB1 gene is affected.

And this inherent genetic piece is why the field is moving so fast toward precision medicine and genomics.

How should we define genomics for our audience?

What does it promise?

So genomics is the comprehensive study of the entire set of genes, their functions, and how they interact.

Researchers use tools like genome -wide association studies or Jijue Wus to systematically look for tiny genetic variations—a substitution, a deletion, an addition—that correlate strongly with the disease.

And the power of this is tailoring the treatment, making it personal.

Exactly.

If we can identify a patient subset whose prognosis is linked to a specific molecular abnormality, we can hopefully use a less toxic and more effective therapy.

Can you give us a concrete example of that?

Sure.

For acute lymphoblastic leukemia, or ALL, risk factors include ionizing radiation or Down syndrome.

The associated genomic lesion is often a translocation in the ABL family of genes, identifying that translocation is the key to using specific targeted therapies that bypass traditional chemo.

And for a solid tumor.

Let's take neuroblastoma.

Historically, the treatment was just brutal because it often presents late.

Now we know that if we find ALK point mutations or MYCN oncogene amplification, that dramatically changes the risk in the treatment intensity.

It's the future of reducing long -term side effects.

Which makes that molecular evaluation in the diagnostic stage absolutely essential.

So given this focus on intrinsic factors, what is the role of prevention in pediatric oncology today?

The role is, it's pretty limited for these specific cancers.

We don't have widely recognized preventive measures.

So the professional role shifts to educate the family about carcinogens for adult type cancers.

Things like secondhand smoke, UV exposure, that kind of thing.

And what about early screening?

The source mentions a shift away from self -examination.

That's right.

The focus has moved toward breast self -awareness.

But the most effective preventative measure we have in this space is the HPV vaccination.

It's recommended around age 11 or 12, and it's proven to prevent several malignancies later in life.

That's a key piece of public health messaging for every pediatric nurse.

Okay.

So a child presents with suspicious signs.

The diagnostic evaluation has to be rapid, but also thorough.

Walk us through that.

It's a multi -day process.

You've got the history, physical exam, extensive labs, imaging, specialized procedures, and surgical pathology.

Let's start with the initial lab work.

What are we looking for?

The initial panel is comprehensive.

A CBC, serum chemistries, LFTs, COAGs, a urinalysis.

But the CBC is immediately telling, especially in suspected leukemia,

you often see the triad of bone marrow failure.

Low hemoglobin, low platelets, and really variable white blood cells.

Variable how?

They can be low, they can be dangerously high, or they could be deceptively normal.

What are the metabolic markers that raise the alarm?

We're closely monitoring metabolic products that increase with high tumor burden and rapid cell turnover.

So you're looking for elevated LDH, creatinine, and uric acid.

Why are those so critical?

Because their elevation, especially as treatment starts, signals the potential onset of an oncologic emergency we'll talk about later, tumor lysis syndrome.

Separately, with a solid tumor, elevated alkaline phosphatase might point to bone metastasis.

Okay.

Moving to the key invasive procedures.

The text highlights two, lumbar puncture and bone marrow aspiration.

Right.

The LP is routine for any child with leukemia or a brain tumor because of the high risk of CNS involvement.

We do it to see if cancer cells are in the spinal fluid.

But it's also the delivery route for intrathecal chemo -intracting it directly into the spinal canal to bypass the blood -brain barrier.

And the bone marrow assessment.

That's essential for confirming leukemia and identifying its specific subtype, which dictates the entire treatment protocol.

For solid tumors like neuroblastoma, we use it to see if it's spread to the marrow.

This brings us back to the pathology lab and the molecular evaluation.

We can't just rely on what the cells look like anymore.

Not at all.

For solid tumors, the biopsy provides tissue not just for diagnosis, but for risk stratification.

For example, identifying MYCN oncogene amplification in a neuroblastoma patient instantly flags that child for higher risk, more intensive therapy.

Because it's correlated with relapse.

Exactly.

Targeted therapy is entirely dependent on finding these specific abnormalities.

Finally, diagnostic imaging.

We're talking x -rays, CT, MRI, PET scams.

But there's a significant safety responsibility here with radiation exposure.

This is a huge concern for growing children.

They're more susceptible to the long -term effects of cumulative radiation.

The nurse has to be aware of and advocate for the Image Gently campaign.

What's the core principle of that?

It's focused on optimizing imaging techniques to use the lowest possible radiation dose to get a good image.

It's about following the ALRA principle, as low as reasonably achievable for every single image.

Okay, let's pivot to treatment.

As we've established, those improved survival rates are from a highly coordinated multimodal approach.

Right.

It's a combination of surgery, chemotherapy, biologic therapy, HSCT, and radiation, often through these big cooperative group clinical trials.

Let's start with surgery.

The goal seems straightforward.

It is.

Maximum tumor removal and restoration of function.

It's most successful when a tumor is localized and encapsulated.

But chemo has really changed the surgical approach.

How so?

For bone cancers like osteosarcoma, we're seeing a massive shift toward conservative excision, or limb salvage, over immediate amputation.

The focus is on preserving the limb, function, and appearance, followed by intensive post -op chemo.

Next up is radiation therapy.

This can be for cure or for paliation.

How does it actually work?

It causes its cytotoxic effects by damaging DNA and RNA, causing breaks in the strands.

The acute side effects we see are directly related to the lethal damage done to rapidly proliferating normal cells, bone marrow, GI tract, hair follicles.

Okay, so this brings us to managing those acute side effects.

Let's start with the GI tract.

For nausea and vomiting, the critical intervention is timing.

You administer antibiotics around the clock, not just when they feel sick, and you give them before the chemo starts.

We'll get more into that later.

And for anorexia?

Monitor weights carefully.

Encourage small, frequent light meals.

If there's diarrhea, we give antispasmodics and watch for dehydration.

What about the visible and often really emotionally distressing side effects on the skin and hair?

For alopecia, hair loss, the nurse's role is preparatory.

Encourage them to pick out a wig before the hair loss begins.

Emphasize gentle scalp hygiene and the need for a head covering for sun and temperature regulation.

And for skin irritation.

A crucial alert here.

Do not use the word burn.

That language is psychologically damaging.

We only use mild soap, we avoid friction, and importantly we do not remove the skin markings from the radiation oncologist.

And what's the most dangerous acute side effect from radiation?

Myelosuppression in the bone marrow.

This leads directly to neutropenia and infection risk.

The nursing intervention is immediate observation for fever, a prompt sepsis workup, immediate broad spectrum antibiotics, and instituting bleeding precautions.

And with that, there's a major safety alert.

Yes.

Absolutely avoid all rectal interventions.

No rectal temps, no suppositories.

The risk of mucosal trauma and introducing infection is just too high.

You mentioned an incredible advancement, proton beam radiation.

Why is this so much better, especially for a child?

The physics are just fundamentally different.

Traditional radiation deposits energy as it enters and exits the body.

Protons, however, deposit their energy at a precise depth and then they just stop.

But there's no exit dose.

Exactly.

No exit dose beyond the tumor.

For a child getting spine radiation, for example, this completely spares vital organs like the heart and lungs, minimizing lifelong late effects.

It's a massive step forward in survivorship quality.

That really shifts the paradigm.

It's not just about a cure, but a quality of life afterward.

Let's transition to chemotherapy.

Chemo is the backbone of most pediatric protocols.

It works by interfering with nucleic acid production or function.

The standard is combination regimens, using multiple drugs to maximize cell destruction and minimize resistance.

The administration requires the nurse to be so vigilant about safety.

What are the key alerts?

First, using venous access devices or VADs is crucial for safe and consistent delivery.

Second, we have to remember that almost all these drugs are non -selectively cytotoxic.

They kill cancer cells, but they also kill the normal rapidly dividing cells.

And that's where the side effects come from.

That's right.

And that brings us to the specific danger of vesicans.

Define that for us.

A vesican is a drug that, if it leaks out of the vein, cause severe tissue death and ulceration.

It can be devastating.

So what's the nursing alert here?

It's absolute.

Vesicans must be given through a perfectly free -flowing VIVE line.

If you see any sign of infiltration pain, stinging, swelling, redness, you stop the infusion immediately and initiate the extravasation protocol.

There's also the immediate systemic risk of anaphylaxis.

For high -risk agents, protocol dictates the child is observed for a full hour post -infusion.

Emergency equipment monitor, oxygen, suction, and emergency drugs, especially epinephrine, have to be checked and at the bedside before the infusion even begins.

Safety isn't just for the patient.

It's for the nurse, too.

Let's talk about handling these agents.

These guidelines are crucial.

The drugs should only be prepared by trained pharmacy staff and special ventilated hoods.

Nurses administering them must wear disposable protective gear chemo gloves, protective clothing, eye protection, and disposal.

Contaminated equipment goes into specialized leak -proof containers, and crucially, needles must never be recapped or broken.

Beyond traditional chemo, we now have biologic therapy or targeted therapy.

Right, this is the precision end of things.

We categorize it into two main areas.

First is immunotherapy, which stimulates the child's own immune system to attack the cancer.

This includes things like monoclonal antibodies and the incredibly complex ARC RT cell therapy.

What's the unique nursing challenge with RT cell therapy?

The side effect profile is totally different.

Nurses have to be experts in recognizing and managing cytokine release syndrome, or CRS, which can mimic sepsis and neurotoxicity.

And the second type.

Targeted therapies.

These are different because they're designed to interfere with specific molecules or pathways necessary for tumor growth, like those mutations we talked about earlier.

So they're less likely to harm normal cells.

Generally, yes.

But because they're newer, the long -term effects on a child's growth and development must be very carefully monitored.

Our final treatment modality, hematopoietic stem cell transplant, or HSCT.

This is used to restore the body's stem cells after high -dose therapy is wiped out the bone marrow.

We can get stem cells from bone marrow, peripheral blood, or cord blood.

And we distinguish between two major types.

Yes.

Allogeneic uses donor cells.

This requires pre -transplant conditioning, massive doses of chemo and radiation to suppress the recipient's immune system to prevent rejection.

And the primary risk with allogeneic is GVHD.

Correct.

Grav versus host disease.

This is when the donor immune cells recognize the recipient's body as foreign and attack it.

HLA matching is crucial to minimize this.

And the other route is autologous.

Right.

That uses the patient's own stored stem cells.

This eliminates the risk of GVHD, but the prep regimen is still extremely aggressive.

The source makes a strong point about the profound family stress around HSCT.

This is where those family dynamics come into play.

The stress is just immense.

Parents are facing a life or death choice where the prep regimen destroying their child's immune system is irreversible.

There is no rescue if the transplant fails.

They also face months away from home.

The nurse has to provide continual psychosocial support through this terrifying uncertainty.

Let's shift now into the most acute high -stakes area, recognizing and acting on oncologic emergencies.

First up, tumor lysis syndrome or TLS.

TLS results from the massive, rapid destruction of cancer cells, typically in fast -growing cancers like leukemia or Burkitt lymphoma, right after chemo starts.

When the cells burst, they spill all their contents into the bloodstream.

And this spill creates a classic quartet of metabolic abnormalities.

What are they?

The four hallmarks are hyperuricemia, hypocalcemia, hyperphosphatemia, and hyperkalemia.

And which one is the clinical killer, the one we have to manage most aggressively?

While hyperkalemia can cause dangerous cardiac arrhythmias, the one that requires the most aggressive management is hyperuricemia.

The massive load of uric acid rapidly crystallizes in the renal pubules, leading directly to acute kidney injury.

So what is the immediate nursing management plan to prevent that?

Early identification through vigilant lab monitoring is key.

We start aggressive IV hydration to flush the kidneys.

We also use meds.

Alpurinol is given to decrease the production of uric acid.

If TLS is confirmed, we often use rhizburocase, an enzyme that converts uric acid into something highly soluble that the child can excrete easily.

Next, hyperleukocytosis.

This is a purely mechanical problem.

This is when the WBC count is over 100 ,000.

The sheer volume of these non -functional cells increases blood viscosity,

causing sludging and capillary obstruction, especially in the lungs and brain.

What are the clinical signs of that obstruction?

We look for respiratory distress and cyanosis.

But the most alarming signs are neurological.

Confusion, visual changes, headache, delirium.

Management requires rapid cider reduction with chemo, aggressive hydration, and sometimes leukophoresis.

Let's discuss superior vena cava syndrome, SVCS.

SVCS is caused by compression of the superior vena cava, usually by a mass in the chest, like from Hodgkin or non -Hodgkin lymphoma.

This obstructs venous return from the head, neck, and upper chest.

What are the telltale clinical signs?

Cynosis of the face, neck, and upper chest.

Edema in the face and upper extremities.

Distended neck and chest veins.

The child will look anxious and short of breath.

The nursing priority is immediate airway protection and getting treatment started to relieve that pressure.

Spinal cord compression.

This is an emergency defined by its risk of irreversible neurological damage.

It happens when malignancies invade or impinge on the cord.

And the initial sign, the one that is so often missed or dismissed, is simple back pain.

But if it's missed, the consequences are severe.

Absolutely.

It progresses quickly to sensation changes, weakness, and loss of bowel or bladder function.

Diagnosis is by MRI.

Treatment is immediate, high -dose steroids to reduce edema, followed by emergent radiation or surgery.

Finally, disseminated intravascular coagulation, or DIC.

DIC is a catastrophic complication, usually triggered by overwhelming sepsis in an immunocompromised child.

It's a hyperactivation of the clotting cascade.

You get all these micro thrombies forming, but that process rapidly consumes all the body's clotting factors and platelets.

And the result of that consumption?

The child switches from clotting to bleeding.

We worry about life -threatening hemorrhage.

Treatment requires treating the underlying infection, giving heparin to slow the micro thrombie, and replacing the consumed factors with plasma or a cryoprecipitant.

Okay, that covers the emergencies.

Now let's get into the daily reality of pediatric oncology care, the foundational skills every nurse has to master.

Right.

Managing the acute side effects of treatment.

Let's begin with the baseline assessment.

What are the key symptoms parents report that should trigger an immediate investigation?

The warning signs are crucial.

Any unusual mass or swelling,

unexplained paleness or fatigue,

easy bruising,

persistent localized pain or limping, prolonged unexplained fever,

frequent headaches, especially with vomiting,

sudden vision changes, or rapid weight loss.

Let's plot a few of those.

First, pain.

Pain is complex,

but bone pain is a common presenting sign of leukemia because of the increased pressure inside the bone marrow.

In masses.

An abdominal mass is a classic presentation for Wilms tumor or neuroblastoma.

What about that unique visual sign associated with retinoblastoma?

Leukocorrhea, or the cat's eye reflex.

This is a whitish glow in the people that parents might notice in flash photographs.

It requires immediate urgent attention.

Okay, let's talk about our highest yield priority, the critical nursing measure that prevents death, managing infection due to neutropenia.

What's the danger threshold we have to memorize?

The danger threshold is an absolute neutrophil count, or ANC, of less than 500 per cubic millimeter.

At this level, the child has essentially no immune defense and is at high risk for overwhelming infection and septic shock.

Walk us through the ANC calculation since this defines the patient's immediate risk.

You take the percentage of segmented neutrophils, or polys, plus the percentage of bands, the immature ones.

You convert that total percentage to a decimal and multiply it by the total WBC count.

So, for example.

If a child's WBC is 1200 and they have 5 % segs and 5 % bands, that's a total of 10%, or 0 .10, you multiply 0 .10 by 1200 and you get an ANC of 120.

That patient needs profound protective care.

If a neutropenic child spikes a fever, what's the immediate action sequence?

Time is life here.

Close temperature monitoring, often every four hours.

If a fever over 38 .3 Celsius is detected, even with no other signs of infection broad spectrum, IV antibiotics must be started immediately before you even know the organism.

And we also use colony stimulating factors, right?

Yes.

Agents like GCSF, or filgrastem, are routine.

They promote rapid maturation of granulocytes, which decreases the duration of neutropenia and lowers infection risk.

And what are the key home care instructions for the family?

Meticulous hand washing is paramount.

They need clear instructions on measuring temperature and what to do if there's a fever.

If the ANC is below 500, we recommend cautious isolation, avoiding crowded public areas, no fresh flowers or plants.

Okay, let's move to the second major risk, hemorrhage and anemia.

Hemorrhage risk is managed by platelet transfusions, typically for active bleeding or if the count is below 20 ,000.

The nursing priority is prevention,

avoiding invasive procedures, and reiterating that absolute ban on all rectal interventions.

And family teaching.

Teach simple measures for nose bleeds, caution against contact sports, and crucially instruct them to avoid all aspirin and aspirin -containing products.

Acetaminophen is the go -to.

Anemia is managed with packed RBC transfusions if symptoms are severe.

Chemotherapy -induced nausea and vomiting, or CINV.

The experience has improved, but nursing diligence is still so critical.

The pharmacological advances, especially the 5 -HT3 receptor antagonists or serotonin blockers, have been transformative.

They don't have those severe extrapyramidal side effects.

But the timing of the anti -medic is the most critical nursing intervention.

Why?

It's not just about comfort.

It's about preventing a conditioned response.

The anti -emetic must be given prophylactically 30 minutes to an hour before chemo begins and continued on a regular schedule.

So it's all about getting ahead of it.

Exactly.

The goal is the child never experiences nausea.

If they do, they can develop anticipatory symptoms, where just the sight or smell of the clinic triggers vomiting.

Once that's established, it's incredibly difficult to reverse.

Let's address nutrition and mucosal ulceration.

Nutritional status is tied directly to outcome.

Routine nutritional assessment is a must,

and a profound nursing alert related to CINV is.

Refrain from offering the child's favorite foods during chemotherapy.

This prevents them from developing those conditioned aversions.

And if the child is anorexic?

We encourage high -calorie, high -protein supplements.

Using whole milk, adding butter, nutrient -dense snacks.

If they can't maintain oral intake, we may need tube feeding or TPN.

Ucosal ulceration or stomatitis is intensely painful and a gateway for infection.

What's the management protocol?

Meticulous oral hygiene with a soft toothbrush or tooth -of -head.

Bland, moist, soft diet.

Frequent rinsing with things like sodium bicarbonate and salt.

We can use local anesthetics, like a defenhydramine and malox mixture.

But there's a major safety alert here.

A huge one.

Avoid viscous lidocaine in young children.

The risk of rapid systemic absorption through the ulcers is high, which can lead to seizures.

It can also depress the gag reflex, increasing aspiration risk.

Also avoid lemon glycerin and hydrogen peroxide because they're drying and irritating.

Moving to drug -specific neurologic problems.

Vincristine is notorious.

It is.

The most common GI side effect is severe constipation from decreased bowel innervation.

So we start a school softener proactively.

Neurologically, it causes foot drop, weakness, and numbness.

They also can get severe jaw pain, which is sometimes relieved by continuous chewing.

What about hemorrhagic cystitis?

This is sterile inflammation and bleeding of the bladder from drugs like cyclophosphamide.

Prevention is key.

Literal fluid intake, frequent voiding, and administering mezna, a chemoprotectant drug that detoxifies the metabolites.

Nursing alert.

If the child reports burning on urination, it requires immediate medical investigation.

Finally, managing the body image changes from steroids and alopecia.

For alopecia, the emotional support is paramount.

Warn them that hair loss is rapid.

Encourage them to select a wig or hat before the hair loss occurs to give them a sense of control.

And the steroids.

They induce a temporary Cushingoid appearance, a rounded puffy face, fat pads.

It's vital to reassure them that these changes are temporary and will resolve.

Also warn parents that the drugs can cause severe mood changes, which are drug -induced effects, not behavioral choices.

Let's transition to the specific diseases, starting with the most common childhood cancer.

Acute leukemias.

Right.

The underlying pathophysiology guides everything.

It's the uncontrolled proliferation of immature, non -functional white cells leading to competition and replacement in the bone marrow.

This bone marrow dysfunction is the source of all the initial clinical signs.

So walk us through the consequences of that bone marrow replacement.

It leads to the core triad.

First, decreased RBC production leads to anemia, that's the pallor in fatigue.

Second,

decreased normal WBC production leads to neutropenia and infection.

Third, decreased platelet production leads to thrombocytopenia and hemorrhage, the bruising and petechiae.

And the increased pressure in the bone causes the bone and joint pain.

And the cancer doesn't stay in the marrow.

No, it infiltrates organs, causing enlarged spleen, liver, and lymph nodes.

And crucially, it infiltrates the CNS and testes.

These are called sanctuary sites because systemic chemo often can't reach them.

Therapeutic management is intensive and structured into three distinct phases.

Let's start with phase one.

Phase one is remission induction.

It lasts four to five weeks.

The goal is complete remission less than five percent blast cells in the marrow.

Key drugs are corticosteroids, vincristine, and L -asparaginease.

Supportive care during the profound myelosuppression is critical.

And phase two.

Consolidation intensification.

This phase is about eradicating any residual disease.

It involves continued high -dose systemic therapy plus CNS prophylactic therapy and trithiclochemo to get into those sanctuary sites.

And phase three.

Maintenance.

This is where adherence becomes a major issue.

It lasts two to three years.

It involves daily oral mercaptopurine and weekly methotrexate.

And this is the crucial nursing alert.

Adherence is paramount.

Studies show less than 95 percent adherence dramatically increases the relapse risk.

The nurse's role is continuous guidance and reinforcement over this very long period.

Let's move to lymphomas.

Starting with Hodgkin lymphoma or HL, this is mainly a disease of adolescence.

Right.

Often associated with the Epstein -Barr virus.

It typically originates in lymph nodes and spreads predictably.

The classic presentation is a painless and large lymph node, usually firm, non -tender, and movable in the neck or collarbone area.

The presence of B symptoms is a critical staging determinant.

Yes.

B symptoms indicate advanced systemic disease.

These are unexplained fever, drenching night sweats, or significant weight loss.

Diagnosis requires a biopsy to find the Hallmark Hodgkin and Reed Sternberg cells.

Prognosis is excellent.

For teens, the nursing care focus shifts to long -term quality of life.

Absolutely.

The treatment puts them at risk for delayed sexual maturation and, critically, infertility.

Nurses have to proactively counsel them on fertility preservation options before treatment starts.

It's a sensitive but essential discussion.

And non -Hodgkin lymphoma, or NHL, is actually more common in children.

Yes.

And it's much more aggressive and generally widespread at diagnosis.

It can mimic leukemia.

The lymphoid tumors can cause things like intestinal or airway obstruction, presenting as acute emergencies.

Treatment is intensive combination chemo, similar to leukemia.

Okay.

Let's turn now to solid tumors, starting with nervous system tumors.

The location of the tumor dictates the symptoms more than anything else.

That's the core principle.

Roughly 60 % of pediatric brain tumors are infertitorial in the cerebellum or brainstem.

Because this is a narrow area for CSF circulation, they most often cause symptoms of increased intracranial pressure, or ICP.

And what are those cardinal ICP signs that demand immediate attention?

You have to look for a classic triad.

First, headache, which is typically worse on waking and intensified by straining.

Second, vomiting, which can be projectile and happens with or without nausea.

Also often worse in the morning.

And then changes in neuro status.

And for diagnosis, MRI is the gold standard.

It is.

And a critical safety consideration.

A lumbar puncture is contraindicated if you suspect increased ICP.

The sudden pressure release can cause brainstem herniation.

Let's discuss the high -yield postoperative nursing priorities after a craniotomy.

Three non -negotiable areas.

Assessment, positioning, and fluid management.

For assessment, vitals every 15 to 30 minutes and immediately report any change in pupillary status.

Sluggish, dilated, or unequal pupils are a sign of rapidly increasing ICP.

And what are we looking for on the dressing?

You check it frequently for drainage.

Colorless drainage must be reported immediately.

That is a CSF leak.

Positioning is based strictly on the surgical site.

For infertentorial surgeries, in the back, the child is kept flat on either side with the head and neck strictly midline.

For supertentorial surgeries, the head is usually elevated above the heart to facilitate CSF drainage.

The universal no -no is the Trendelenburg position, which significantly increases ICP.

Next, neuroblastoma.

This is a tumor of neural crest origin, a disease of early childhood, and is notorious for being a silent tumor.

More than 70 % of cases are diagnosed after it's already metastasized.

What's the classic presentation?

The most common primary site is the abdomen.

It's a firm, non -tender, irregular mass.

The critical differentiator is that the neuroblastoma mass typically crosses the midline.

We also track urinary excretion of VMA and HVA for diagnosis and monitoring.

Moving to bone tumors, osteosarcoma and Ewing sarcoma.

These primarily affect adolescents.

Osteosarcoma, or OS, is the most common, found in the long bones, and is not sensitive to radiation.

Ewing sarcoma, or EWS, arises in the marrow spaces and is sensitive to radiation.

And the presentation is often vague.

Localized pain, often blamed on growing pains.

Limping, a palpable mass.

Treatment for OS is chemo, then limb salvage surgery, then more chemo.

EWS involves surgery, radiation, and chemo.

The nursing challenge post -surgery is often managing phantom low pain.

It affects the majority of patients after an amputation.

The nurse has to reassure the child and family that the sensation of pain in the missing limb is real.

It's a neurological phenomenon not in their head.

Wilms tumor, or nephroblastoma, the most common kidney tumor.

Average age is around 44 months.

The classic sign is a mass in the abdomen that is characteristically firm, non -tender, confined to one side, and deep in the flank.

Crucially, it does not cross the midline.

The nursing priority here is the single most important safety alert for this disease.

Nursing alert.

Do not palpate the abdomen unless absolutely necessary.

The tumor is encapsulated, and manipulation risks rupturing it, which automatically makes the stage worse and requires much more toxic therapy.

A clear sign has to go in the bed.

Finally, retinoblastoma.

Most common intraocular malignancy of childhood.

The cardinal sign is that whitish glow in the pupil, the cat's eye reflex, or leukocorrhea, often only seen in flash photos.

And treatment aims to save the eye if possible.

Yes, with local therapies and chemo.

Inucleation, or eye removal, is for advanced disease.

If that's necessary, the most critical long -term safety concern is protecting the unaffected eye with protective eyewear.

They also need lifelong follow -up due to a high risk of subsequent malignancies.

With improved cure rates, the final and most important responsibility is focusing on health promotion and lifelong survivorship.

Care doesn't end when chemo stops.

That is the modern reality.

We start with essential supportive care, like dental health, which is crucial because of late effects.

We encourage brushing and flossing, but only if blood counts are safe.

And immunizations require a severe safety alert.

Safety alert.

Children on chemo must not receive live, attenuated vaccines, MMR, varicella, or polio.

The risk of getting the full -blown disease is too high.

Also, any vaccine given during or right before chemo is considered ineffective, and they need revaccination six months after chemo is done.

Finally, the immense challenge of late effects.

Survival is excellent, but it comes at a cost.

It's the double -edged sword of success.

While 80 % survive, 60 % to 90 % of adult survivors develop one or more chronic health conditions.

Cardiac dysfunction, subsequent cancers, endocrine problems.

So the nursing role transitions from acute care manager to lifelong risk manager.

Exactly.

The nurse ensures ongoing adherence to the long -term follow -up guidelines, which dictates lifelong screening based on the specific treatments the child received.

This holistic view is the essence of modern pediatric oncology nursing.

This has been an incredibly detailed and vital deep dive.

As we conclude, let's distill the three highest -yield clinical priorities for our audience.

First, the vigilance triangle.

Neutropenia, fever, and oncologic emergencies.

You have to know the ANC threshold of less than 500 and start the sepsis protocol on a fever.

You have to instantly recognize the signs of TLS.

Second, mastering prevention and meticulous physical care.

Right.

This is the clinical rationale behind your actions.

Giving antibiotics proactively.

Avoiding viscous lidocaine and that strict ban on all rectal interventions.

And finally.

Prioritizing safety unique to the disease.

Remembering the absolute rule to never palpate the abdomen in the suspected Wilms tumor patient.

Maintaining the precise positioning after a craniotomy.

And protecting the solitary remaining eye in a retinoblastoma survivor.

These are the anchors of safe practice.

As therapeutic advances continue, the nursing role is shifting.

What does this mean for the future?

It means we are generating a larger population of survivors than ever before.

The next generation of oncology nurses won't just be experts at managing the acute crisis.

They'll become essential partners in guiding these survivors through a lifetime of tailored risk management.

They have to ensure that the quality of life they saved matches the longevity of life they gained.

A truly vital and evolving calling.

Thank you for guiding us through this essential material.

My pleasure.

And thank you for joining us for the Deep Dive.

We'll be back next time with another stack of sources to unpack.